Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation
Meiling Jin,1,2,* Wenwen Ren,3,* Weiguang Zhang,2 Linchang Liu,2,4 Zhiwei Yin,2,5 Diangeng Li6 1Department of Nephrology, Beijing-Chaoyang Hospital, Capital Medical University, Beijing, 100020, People’s Republic of China; 2Department of Nephrology, Chinese People’s Liberation Army Ge...
Guardado en:
Autores principales: | Jin M, Ren W, Zhang W, Liu L, Yin Z, Li D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f024dec572f47e7acabbe52e6101116 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanism of Tongxie Yaofang in the treatment of colorectal cancer based on network pharmacology and molecular docking
por: Ling-Xia Yang, et al.
Publicado: (2021) -
Study on the mechanism of Guizhi Fuling pill in the treatment of ovarian cancer based on network pharmacology and molecular docking
por: Xiao-Qing Wu, et al.
Publicado: (2021) -
Study on the Mechanism of Baimai Ointment in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking with Experimental Verification
por: Yingyin Zhu, et al.
Publicado: (2021) -
Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis
por: Geng,Wenjia, et al.
Publicado: (2016) -
Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Bushen Huoxue for the Treatment of Premature Ovarian Insufficiency
por: Ying Cao, et al.
Publicado: (2021)